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Abstract 
Background: 
The use of different bioactive materials as coating on dental implant to restore tooth 
function is a growing trend in modern Dentistry. In the present study, hydroxyapatite 
and the bioactive glass-coated implants were evaluated for their behavior in osseous 
tissue following implantation in 14 patients. 
Materials and Methods: 
Bioactive glass and hydroxyapatite formulated and prepared for coating on Ti-6Al-4V 
alloy. Hydroxyapatite coating was applied on the implant surface by air plasma spray 
technique and bioactive glass coating was applied by vitreous enameling technique. 
Their outcome was assessed after 6 months in vivo study in human. 
Results: 
Hydroxyapatite and bioactive glass coating materials were nontoxic and 
biocompatible. Uneventful healing was observed with both types of implants. 
Conclusion: 
The results showed bioactive glass is a good alternative coating material for dental 
implant. 
Keywords: Bioactive glass, bioactive materials, biocompatible, hydroxyapatite, 
osseous tissue  
INTRODUCTION 
With the recent advancement in the field of biomaterials, a renewed interest has been 
focused on the research on dental implantology, more specifically in the area of 
implant-tissue interface. As bio-inert materials often become encapsulated in fibrous 
tissue, it is important to develop new biomaterials that will ensure extended lifetime 
of implant performances.[1] A bioactive material (i.e., Calcium phosphate ceramics, 
glass-ceramics) has a behavior to create a bond between the living tissue and the 
prosthesis as well as their chemical composition can be adjusted to obtain the desired 
bioactive properties.[2] Synthetic hydroxyapatite (HA) is a totally biocompatible, 
osteoconductive material,[3] and has a close structural and chemical resemblance to 
bone mineral, but not identical.[4] Thus, HA have a capacity to deceive the living 
bone tissues behaving as a natural bone.[5] Bioactive glass ceramics (BG) have 
osteoproductive and osteostimulatory properties[6] and when exposed to tissue fluid, 
promote proliferation and differentiation of osteoblast cells to form an extracellular 
matrix and mineralization.[7] It has been established that BG have good mechanical 
property and higher bioactivity in comparison to HA.[8,9] Consequently, the material 
has become a better choice to be used as a coating on metallic implants. The present 
study has been undertaken to develop a suitable bioactive glass composition for 
coating on single tooth dental implant, fabricated from titanium alloy (Ti6Al4V) and 
to evaluate the behavior of the BG-coated and HA-coated titanium dental implants in 
human jaw bone. 
MATERIALS AND METHODS 
The study was carried out in the Department of Periodontics, Dr. R. Ahmed Dental 
College and Hospital, Kolkata, in association with Bioceramic and Coating Division 
of Central Glass and Ceramic Research Institute, Kolkata, from January to December 
2008. It was approved by Institutional Ethical Committee of Dr. R. Ahmed Dental 
College and Hospital, Kolkata. 
Fabrication of Ti-6Al-4V alloy dental implant 
Titanium alloy (Ti6Al4V) material (5 mm × 5 mm bar) was procured.
¶
 The internal-
hex, cylindrical, threaded, two-staged dental implant system (4 mm diameter × 13 mm 
length) was designed and fabricated [Figure 1] in Central Glass and Ceramic Research 
Institute, Kolkata. The indigenous implant system consists of implant itself, 
healing/cover screw, abutment screw and metallic gingival former. The implant had 
crestal module height - 1.5 mm, pitch - 1 mm, and thread depth - 0.25 mm. The 
abutment screw (length - 7 mm) was 5° taper coronally ([Figure 1], inset). 
Preparation of hydroxyapatite 
In this study, calcium nitrate tetrahydrate
£
 [Ca(NO3)2.4H2O], and di-ammonium 
hydrogen ortho-phosphate£ [DAP, (NH4)2HPO4] were used as raw materials. Glycine
§
 
(C2H5NO2) was used as fuel. Aqueous stock solutions of calcium nitrate tetrahydrate 
(2.72 M) and DAP (2.09 M) were mixed in the ratio of 1.67, which are required for 
formation of hydroxyapatite. A few drops of concentrated nitric acid
†
 were added to 
dissolve the resulting white precipitate to make a clear homogeneous solution. The 
detailed method of synthesis was reported elsewhere.[10] The as-synthesized products 
were typically voluminous, fluffy foam-like mass that occupied a large volume. The 
resulting soft-agglomerated powder was readily ground manually in an agate 
mortar/pestle into fine powder and was thoroughly characterized. 
¶
 Mishra Dhatu Nigam, Hyderabad, India. 
£
 S.D. Fine-Chem. Ltd., India. 
§
 Glaxo, Qualigens, India. 
†
 Merck, India. 
Preparation of bioactive glass 
The suitable bioactive glass was prepared using a conventional glass melting 
technique. The appropriate amounts of reagents/raw materials silica (SiO2), calcium 
carbonate (CaCO3), dry soda ash (Na2CO3), decahydrated borax (Na2B4O7.10H 2O), 
TiO2, DAP were mixed together in water or acetone. The mixture was thoroughly 
dried at 120°C to remove the liquid completely, and then heated in air at temperature 
1000°C for 1 h for carbonate decomposition and finally melted at 1400°C for 1 h in a 
platinum crucible. The melt was quenched in distilled water to obtain flaky glass 
particles, dried and stored for subsequent use; alternatively the melt was poured in a 
preheated steel mould and annealed at 500°C for 30 min. The frit was subsequently 
milled to fine powder in aqueous medium using alumina balls in a mill for 4-8 h. The 
batches used to prepare bioactive glass (BG) consist of SiO2=43-44 wt. %, 
Na2B4O7.10H2O=6-7 wt. %, Na2CO3=11-12 wt. %, CaCO3=29-30 wt. %, 
(NH4)2HPO4=8-9 wt. %, TiO2=1-2 wt. %] and the resultant frit was characterized by 
different in vitro techniques.[9] 
Cytotoxicity test 
In vitro cytotoxicity test was performed at Tissue Culture Laboratory, Sree Chitra 
Thirunal Institute for Medical Sciences and Technology, Tiruvananthapuram, India, 
for both coating materials. 
Powder morphology and particle size 
The particle morphology and the agglomerate structure of HA and BG were 
investigated using a scanning electron microscope (SEM) before coating on dental 
implant. 
Fabrication of coating on Ti-6Al-4V implants 
The surface to be coated was mechanically cleaned to the required roughness by sand 
blasting technique and ultrasonically cleaned to remove any chemical impurity using 
different cleaning agent (acetone). HA coating was applied on the implant surface by 
air plasma spray technique (i.e., argon gas as vehicle and heat source) using a table 
top micro-plasma spray machine 
#
 [Figure [Figure2a2a and andb].b]. BG coating was 
applied on the implant surface by conventional vitreous enameling technique at 800–
820°C in ambient atmosphere [Figure [Figure3a3a and andb].b]. The thickness of the 
coating was within the range of 70–100 µm. Coating material was not applied on 
coronal 2 mm and apical 3 mm of the implant body [Figure 4]. 
Packing and sterilization of coated Ti-6Al-4V dental implants 
Each component of Ti-6Al-4V dental implants was ultrasonically cleaned to remove 
any chemical impurity using cleaning agent (acetone), dried and packed in an air tight 
plastic pouch. All the implant systems were finally sterilized by gamma radiation 
(GAMMA CHAMBER 5000).The human study was carried out in the Department of 
Periodontics, Dr. R. Ahmed Dental College and Hospital, Kolkata. Fourteen 
systemically healthy patients (10 males and 4 females), aged 20-54 years (mean age - 
36 years) were selected for this study. A total of 28 implants (14 HA-coated Ti, 14 
BG-coated Ti implants) have been placed in 14 patients. Twelve implants were placed 
in anterior maxilla and 16 implants were placed in anterior mandible. A written 
consent for this study was obtained from all the patients after explaining the pros and 
cons of the study and before initiation of any sort of treatment. 
Patient evaluation 
Patients enrolled in this study were partially edentulous and indicated for an implant 
supported fixed prosthesis (crown/bridge) in the anterior sextant of both maxilla and 
mandible. Patients’ extensive medical and dental history, clinical examination, oral 
hygiene habits, anatomic acceptability (i.e., alveolar ridge height and `width, vital 
structure), inclusion (i.e., both male and female with age limit of 18–60 years, 
motivated and willing to complete follow up, anterior edentulous areas that 
accommodate at least two implants of same diameter and length, minimum bone 
requirements were 6 mm of alveolar ridge width and 18 mm of ridge height, good 
general health, and oral hygiene habits, no history of previous implant failure or 
invasive perio-therapy for the past six months at the recipient site) and exclusion 
criteria (i.e., careless, non co-operative patients, pregnant or lactating women, patients 
having tobacco habit, history of radiation therapy, presence of systemic diseases, 
severe parafunctional habit) were thoroughly assessed before admitting a patient in 
the study.[11] 
#
 Spraymet, Bangalore, India. 
Operative procedures 
Phase-I therapy was completed and oral hygiene instructions were given to the 
patients at least one month prior to surgery. Stage-1 surgery was performed for 
implant placement and exposure of head (Stage-2 surgery) after three months of 
Stage-1 surgery in aseptic conditions. After extraoral and intraoral disinfection and 
local anaesthesia application, crestal incision was given 1.5 mm short of gingival 
margin of the adjacent teeth that was modified at both the ends extending labially and 
lingually within the confines of attached gingiva. Full thickness flap was elevated 
both labially and lingually to expose the top of the alveolar ridge. A low speed, high 
torque (850–1250 rpm, 20–50 Ncm) drilling system (i.e., physio-dispenser) with 
copious normal saline irrigation were used to minimize excessive heat generation and 
trauma to the bone.[12] A surgical template or stent was placed on the occlusal table 
of same arch to direct accurate placement of implant and 2.5 mm diameter drill bit 
was used to penetrate at least 3–4 mm crestal bone for all the osteotomy sites. The 
stent was then removed and the facio-lingual and mesio-distal dimensions of the 
osteotomy sites were checked by inserting similar diameter guide pins. Keeping the 
guide pins inserted in the other sites, the same drill bit was used to establish the 
required depth (i.e., 13.5 mm) of osteotomy sites one by one to ensure accurate 
parallelism of two prepared sites. Holes were drilled 0.5 mm in addition to implant 
length to assure the level of implant at or just below the level of crestal bone as all 
two staged osseointegrated implant system confirm early post operative crestal bone 
loss as a result of surgery. According to implant size, same diameter drill bit (4 mm) 
was chosen as last widening drill for final osteotomy site preparation. All the drilling 
procedures were accomplished with steady hand, without wobbling to minimize 
funneling of the coronal portion of the osteotomy sites. No tap was used but 
countersinking was utilized in few cases. Implants were threaded into place without 
touching its surface, at the level of bone using hand wrench. Almost all the implants 
achieved primary stability at the time of placement except two. After placement, 
healing cover screw was threaded over the implants and tension free primary flap 
closure was obtained with a combination of horizontal mattress suture and interrupted 
sutures or continuous locking suture to ensure complete sealing of wound edges, 
preventing saliva contamination and to maintain a sterile environment around the 
implant. 
Patients were given topical (0.2% chlorhexidine) and oral antimicrobials (500 mg 
amoxycillin thrice daily × 7 days), analgesic medications (400 mg ibuprofen thrice 
daily × 2 days with antacids) and routine post surgical instructions before release from 
clinic. Two weeks after Stage-1 surgery, the sutures were removed and the patients 
were instructed to gently brush the area with an ultra soft bristle toothbrush. Similar to 
Stage-1 surgery, routine post surgical instructions and medications were given to the 
patients after Stage-2 surgery. After two weeks of Stage-2 surgery, abutment screw 
was screwed into the implant body in place of gingival former and temporary 
prosthesis was fabricated. Patients were then recalled after one week to receive 
permanent restoration [Figure 5]. 
Implant-soft tissue interface was evaluated by plaque index (PI),[13] gingival index 
(GI),[14] probing pocket depth (PPD) distance from the gingival margin to the base of 
the probable crevice).[15] The clinical parameters were recorded with the help of a 
University of North Carolina (UNC-15) probe
g
 for each implant site. 
Implant-hard tissue interface was evaluated by: 
Measurement of crestal bone loss in Intra-Oral Peri Apical (IOPA) X-ray: In 
determining actual bone loss, radiographic measurements of bone level were 
calibrated using divider and caliper with 1/10 mm gradation. The measurements from 
the top of the abutment to the point of bone-implant interface was calibrated using the 
known (i.e., L1=implant + abutment length) and radiographically measured distance 
from fixed reference point (i.e., top of the abutment) to the apical end of implant (L2). 
The actual average bone level of each implant measured multiplying the average bone 
level in radiograph (X’) by the ratio of the L1 to L2 [X (unknown)/X’ (known)=L1 
(known)/L2 (known)]. Deduction of abutment length from actual average bone 
level(X) of baseline or X of subsequent follow-up represents the actual marginal bone 
loss of each implant at that visit because no marginal bone loss was considered at the 
time of implant placement (implant placed at the level of crestal bone). An implant 
was considered as failed if one or more of the following conditions were identified: 
Clinical mobility (following removal of prosthesis), unresolved chronic pain, implant 
loss, radiolucency around implant.[11] 
γ Hu-Friedy Inc., Chicago 
Statistical analysis 
Statistical analysis was employed to compare crestal bone loss using a software 
program.
§
 To determine differences between the coated titanium implants, changes in 
crestal bone level were analyzed using ANOVA test. For each outcome measurement, 
at least 95% confidence limit was estimated. The present study was not a comparison 
between the two coating materials rather more concerned with their success and 
function in osseous tissue. 
RESULTS AND OBSERVATIONS 
Cytotoxicity test: Results showed no toxicity for both HA and bioactive glass using 
direct contact and extract method using L-929 mouse fibroblast cell [Figure 6]. 
Powder morphology and particle size: Powder used to fabricate the BG implants had 
the particle size in the range of 0.2-20 µm [Figure 7a]. The particle size of HA was 
roughly estimated to be of 0.1-10 from the SEM micrograph [Figure 7b]. 
New indigenous implants were inserted in jaw bone without any difficulty. It was 
found clinically that healing was uneventful, in general. There was almost no sign of 
infection or untoward allergic and foreign-body type of reactions taking place 
postoperatively among the samples studied. In the six months post operative 
radiographic view both types of implant showed intimate bone apposition around 
them [Figure 8]. The range of plaque index, gingival index (GI) and mean probing 
pocket depth (PPD), scores were with in the range of 0-1, 0-1 and 2-3 mm 
respectively throughout the study period for both implant types in either arch. No 
analytical comparison was performed for PI, GI and PPD between the two coating 
materials because all scores were very near to normal limit. Mean average marginal 
bone loss with HA coated and BG coated implants upto six months of prosthetic 
loading in either arch were presented in [Table 1]. Evidence of suppuration, resorption 
of entire areas of HA coating and abnormal mobility with vertical pressure was 
observed with 1 HA-coated implant in lower jaw but no coating resorption and 
suppuration observed with any BG-coated implants after failure. 
§
 SPSS version 11, SPSS Inc., Chicago 
DISCUSSION 
This study was a short term, prospective clinical study. The threaded implant design 
was chosen to provide increased surface area of coating in contact with bone tissue. 
The coating materials (HA and BG) were applied on titanium implant leaving 1–2 
mm from crestal module to prevent early exposure of coating at oral environment 
during function because rough coating may invite more plaque accumulation. 
Apically 3 mm of area was also devoid of coating to facilitate cutting efficiency of the 
implants into bony tissue. 
Plaque index (PI), mean gingival index (GI), and mean probing pocket depth (PPD) 
scores of the two coating materials were very near to normal limit throughout the 
study period in both the arches. This finding suggested that low level of plaque did 
not interfere with healing processes of any particular group. Low GI scores also 
indicate that all the coating materials were biocompatible, non-toxic, did not elicit any 
inflammatory and/or foreign body responses to the tissues and no apparent retardation 
of normal bone healing process around implants occurs, which is primary requisites 
for osseointegration.[16] Probing depth alone might have limited value to provide any 
comparable results because it might be changed with alteration in the position of 
gingival margin.[17] All the values of bone level changes observed in the present 
study were in the direction of bone loss for both coated types.[18] 
Evidence of suppuration and entire resorption of HA coating indicated that local 
acidic environment was a reason for HA coating resorption in infected osteotomy 
sites, similar phenomenon was also observed by Jarcho.[5] The almost intact BG 
coating on failed implant demonstrated that BG produce an alkaline medium around 
the implant through dissolution of alkali ions, that might prevent coating resorption 
upon failure. No suppuration around the failed BG implant was observed, which 
suggested that antimicrobial property of BG might have some role in preventing 
infection.[19] Overall implant failure rate of HA coated implant was higher than that 
of BG coated implant [Table 1] might be due to lack of osteostimulatory property of 
HA or incapability to cope with surgical inaccuracies. 
CONCLUSION 
The BG and HA powder developed is suitable for coating on Ti-6Al-4V implants. The 
overall results showed bioactive glass coated implant is a good alternative coating 
material for dental implant at least under the present experimental condition. 
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Figure 1 
 Implant body, (inset) healing cover screw and abutment screw 
Figure 2 
 Micro-plasma spray technique for HA coating on implant (right) using a- top plasma 
machine (left) 
Figure 3 
 
Conventional vitreous enameling technique for BG coating (left) on implant using 
Vita Vacumat dental furnace (right) 
Figure 4 
 HA coated (left) and BG coated titanium implant (right) 
Figure 5 
 
Intra-oral photograph after placement of permanent restoration 
Figure 6 
 Cellular response after cytotoxicity test on HA (left) and BG (right) by direct contact 
method 
Figure 7 
 
(a) SEM of HA powder and (b) BG powder 
Figure 8 
 I.O.P.A X-ray of HA (left) and BG (right) coated implants 6 months after permanent 
prosthetic attachment in maxilla 
Table 1 
 
Differences in mean marginal bone loss by ANOVA test and number of failures of 
HA coated and BG coated implant in maxilla and mandible after six months of 
prosthetic loading 
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